UCB | Rörelseresultat



Operating Profit Ändra Datum
Alcon AG USD 395M 63M 2024-12
Almirall EUR 53.03M 68.53M 2024-06
Amarin USD -25168000 24.64M 2024-09
argenx SE USD 103.04M 86.87M 2024-12
AstraZeneca USD 2.04B 731M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Galapagos EUR -62720000 8.41M 2024-12
Genmab DKK 2.19B 89M 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
GRIFOLS EUR 371.86M 54.83M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Lonza CHF 534M 194M 2024-06
Merck EUR 1.2B 100M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Orion EUR 92.7M 109.3M 2024-12
Recordati EUR 162.68M 13.82M 2024-09
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 4.09B 1.81B 2024-09
UCB EUR 163M 39M 2024-06
Unibail Rodamco EUR 462.7M 36.05M 2024-12



UCB Rörelseresultat - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.